Thanks Surges and ABDM - this should be a lot clearer for those concerned.
'OBJ has taken the decision to UNDERTAKE SOME OF THE PRELIMINARY TESTING (in vitro and in vivo) internally and provide the results to the targeted companies with which OBJ intends partnering.'
5 million is sound cash-on-hand for OBJ and I'm sure that any Phase 1,2, or 3 Pharmaceutical testing of partnering companies molecules or peptides for example, will be born at the expense of the partnering companies. Preliminary Testing is the key phrase here!
It's helpful for me as well, to thrash these issues out on forums like HC to keep a balanced perspective.
Cheers
- Forums
- ASX - By Stock
- strategic alliances
Thanks Surges and ABDM - this should be a lot clearer for those...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online